FDA WITHDRAWING THREE PAR ANDAs AND 25 VITARINE ANDAs VIA ADMINISTRATIVE RULEMAKING PROCEDURES; ATI SUES AGENCY OVER CHLORZOXAZONE RESCISSION

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".